Faster Genomics-Based Diagnosis May Accelerate Treatment of Myeloid Neoplasms Patients
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Company News, Leukemia |
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MorePosted by Andy Lundin | Jan 17, 2023 | Molecular Diagnostics |
Optical genome mapping can outperform standard tests used for common blood cancers and help make better, more specific, diagnosis.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Cancer |
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read MorePosted by Chris Wolski | Nov 28, 2022 | Flow Cytometry, Lab Automation |
The ongoing clinical laboratory labor shortage is putting a strain on the U.S. healthcare system, but automation can help clinical labs cope.
Read More